This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2008 Sep;35(9):1896-7; author reply 1897.

Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration

Hiroe Toki, Shigeki Momohara, So Tsukahara, Katsunori Ikari

PMID: 18785300

Case Reports

Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration

Hiroe Toki et al. J Rheumatol. 2008 Sep.

. 2008 Sep;35(9):1896-7; author reply 1897.

Authors

Hiroe Toki, Shigeki Momohara, So Tsukahara, Katsunori Ikari

PMID: 18785300

No abstract available

PubMed Disclaimer

Comment on

Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
Baraliakos X, Listing J, Rudwaleit M, Brandt J, Alten R, Burmester G, Gromnica-Ihle E, Haibel H, Schewe S, Schneider M, Sörensen H, Zeidler H, Visvanathan S, Sieper J, Braun J. Baraliakos X, et al. J Rheumatol. 2007 Mar;34(3):510-5. Epub 2007 Feb 1. J Rheumatol. 2007. PMID: 17299842 Clinical Trial.

Similar articles

Shortening infusion times for infliximab administration.
Buch MH, Bryer D, Lindsay S, Rees-Evans B, Fairclough A, Emery P. Buch MH, et al. Rheumatology (Oxford). 2006 Apr;45(4):485-6. doi: 10.1093/rheumatology/kei247. Epub 2005 Dec 13. Rheumatology (Oxford). 2006. PMID: 16352636 No abstract available.
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
Baraliakos X, Listing J, Rudwaleit M, Brandt J, Alten R, Burmester G, Gromnica-Ihle E, Haibel H, Schewe S, Schneider M, Sörensen H, Zeidler H, Visvanathan S, Sieper J, Braun J. Baraliakos X, et al. J Rheumatol. 2007 Mar;34(3):510-5. Epub 2007 Feb 1. J Rheumatol. 2007. PMID: 17299842 Clinical Trial.
Management of infusion reactions to infliximab in patients with rheumatoid arthritis or spondyloarthritis: experience from an immunotherapy unit of rheumatology.
Lequerré T, Vittecoq O, Klemmer N, Goëb V, Pouplin S, Menard JF, Daragon A, Mejjad O, Le Loët X. Lequerré T, et al. J Rheumatol. 2006 Jul;33(7):1307-14. Epub 2006 Jun 1. J Rheumatol. 2006. PMID: 16758513
[Infliximab].
Yoshida N, Hashimoto T, Atsumi T, Koike T. Yoshida N, et al. Nihon Rinsho. 2007 Jul;65(7):1251-8. Nihon Rinsho. 2007. PMID: 17642240 Review. Japanese.
Infliximab induced lupus in patients with rheumatoid arthritis.
Elkayam O, Caspi D. Elkayam O, et al. Clin Exp Rheumatol. 2004 Jul-Aug;22(4):502-3. Clin Exp Rheumatol. 2004. PMID: 15301255 Review. No abstract available.

See all similar articles

Cited by

Clinical and radiologic analysis of on-demand use of etanercept for disease flares in patients with rheumatoid arthritis for 2 years: The RESUME study: A case-control study.
Inui K, Koike T, Tada M, Sugioka Y, Okano T, Mamoto K, Sakawa A, Fukushima K, Nakamura H. Inui K, et al. Medicine (Baltimore). 2018 Sep;97(38):e12462. doi: 10.1097/MD.0000000000012462. Medicine (Baltimore). 2018. PMID: 30235736 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Medical
- MedlinePlus Health Information